Spherix Global Insights
Advertising Networks · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
760 Constitution Dr Ste 204, Exton, Penn...Phone Number
(484) 879-4284Revenue
$15.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Spherix Global Insights
Spherix Global Insights is a hyper-focused market intelligence firm that leverages the company's own independent data and expertise to provide strategic guidance, so biopharma stakeholders make decisions with confidence. The company specializes in select dermatology, gastroenterology, nephrology, neurology, and rheumatology markets.Explore more
Spherix Global Insights Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spherix Global Insights your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Spherix Global Insights has new funding data
Spherix Global Insights, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Spherix Global Insights had a recent Job posting/layoffs
Check if Spherix Global Insights has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Spherix Global Insights launches new products
Congratulate Masked Content for being promoted to Masked Content at Spherix Global Insights
Earning: See what the market has to say on Spherix Global Insights recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Spherix Global Insights is spiking on competitors!
Recommended Actions
Find VP level buyers at Spherix Global Insights
Find more new buyers
Compare Similar Companies to Spherix Global Insights
Compare insights from companies similar to Spherix Global Insights, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spherix Global Insights is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spherix Global Insights is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spherix Global Insights.
Spherix Global Insights Tech Stack
A closer look at the technologies used by Spherix Global Insights
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
Spherix Global Insights News & Media
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
New Spherix Global Insights research finds no clear standard of care beyond second line, creating an opportunity for novel therapies to establish themselves in refractory disease and potentially move earlier in treatment over time. New Spherix Global Insights research finds no clear standard of care beyond second line, creating an opportunity for novel therapies to establish themselves in refractory disease and potentially move earlier in treatment over time.Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies
Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction with current treatment approaches in dermatomyositis and polymyositis. Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction with current treatment approaches in dermatomyositis and polymyositis.Eli Lilly’s Oral GLP-1 Foundayo Trails Novo Nordisk’s Wegovy Pill in Early Obesity Launch Uptake, According to Spherix Global Insights
Despite a more flexible administration profile, Foundayo generated lower first-month prescribing rates than the Wegovy Pill among both primary care physicians (PCPs) and endocrinologists. Despite a more flexible administration profile, Foundayo generated lower first-month prescribing rates than the Wegovy Pill among both primary care physicians (PCPs) and endocrinologists.Real-World CAR-T Delays in LBCL Drive Reliance on Bridging Therapy, According to Spherix Global Insights
Analysis of 187 audited patient charts reveals persistent operational barriers remain common for patients with large B-cell lymphoma (LBCL), reinforcing the role of targeted therapies during the CAR-T treatment journey Analysis of 187 audited patient charts reveals persistent operational barriers remain common for patients with large B-cell lymphoma (LBCL), reinforcing the role of targeted therapies during the CAR-T treatment journey
Read more news
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spherix Global Insights
Sign Up For FreeTo access detailed company insights
Spherix Global Insights is a hyper-focused market intelligence firm that leverages the company's own independent data and expertise to provide strategic guidance, so biopharma stakeholders make decisions with confidence. The company specializes in select dermatology, gastroenterology, nephrology, neurology, and rheumatology markets.... Read More
